Literature DB >> 7545873

Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

D S McLeod1, D J Lefer, C Merges, G A Lutty.   

Abstract

Elevated expression of intercellular adhesion molecule-1 (ICAM-1) as well as E- and P-selectin occurs on the vascular endothelium in a number of disease states and is thought to play an early critical role in the adhesion of circulating leukocytes to the endothelium. The goal of the present study was to investigate the immunolocalization of these molecules in the retina and choroid of postmortem human tissue sections from nondiabetic and diabetic subjects. Whereas ICAM-1 was localized primarily within the choriocapillaris of nondiabetic subjects, immunoreactivity in diabetics was significantly elevated throughout the choroidal vasculature and within retinal blood vessels (P < 0.05). In the choroid, P-selectin was most prominent in veins of the nondiabetic, whereas in diabetics, P-selectin was significantly elevated in arteries (P < 0.001) and veins (P < 0.05) and, in some cases, was also observed in choriocapillaris. P-selectin immunoreactivity was not observed in the retina of any subject. E-selectin immunoreactivity was not observed in choroid or retina in any subjects. Neutrophil numbers per square millimeter of tissue were significantly elevated in diabetic choroid (P < 0.05) and retina (P < 0.001). Our results demonstrate that ICAM-1 and P-selectin are constitutively expressed in the normal choroid and are upregulated in the choroidal vasculature in diabetes, but only ICAM-1 was upregulated in the retina of diabetic subjects. Increased cell adhesion molecule expression may contribute to the retinal and choroidal microangiopathy observed in diabetics by enhancing leukocyte adhesion and consequently the incidence of capillary obstruction and endothelial cell injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545873      PMCID: PMC1870979     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

Review 1.  Granulocyte activation and capillary obstruction.

Authors:  G W Schmid-Schönbein
Journal:  Monogr Atheroscler       Date:  1990

Review 2.  Structure and function of leukocyte integrins.

Authors:  R S Larson; T A Springer
Journal:  Immunol Rev       Date:  1990-04       Impact factor: 12.988

3.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

Authors:  M P Bevilacqua; S Stengelin; M A Gimbrone; B Seed
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

4.  Cytochemical heterogeneity of the glial plasma membrane: 5'-nucleotidase in retinal Müller cells.

Authors:  G W Kreutzberg; S T Hussain
Journal:  J Neurocytol       Date:  1982-02

5.  PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes.

Authors:  E Larsen; A Celi; G E Gilbert; B C Furie; J K Erban; R Bonfanti; D D Wagner; B Furie
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

6.  Primary platelet activation in recent-onset type 1 diabetes mellitus.

Authors:  A M Vicari; A Macagni
Journal:  Scand J Clin Lab Invest       Date:  1990-06       Impact factor: 1.713

7.  Red-cell aggregation and red-cell deformability in diabetes.

Authors:  H Schmid-Schönbein; E Volger
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

8.  A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.

Authors:  R Rothlein; M L Dustin; S D Marlin; T A Springer
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

9.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

10.  Hypoxic viscosity and diabetic retinopathy.

Authors:  T Rimmer; J Fleming; E M Kohner
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

View more
  158 in total

1.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

Review 2.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

Review 3.  Molecular targeting of angiogenesis for imaging and therapy.

Authors:  Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-05       Impact factor: 9.236

4.  The pathogenesis of diabetic retinopathy.

Authors:  M R Stanford
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

5.  Pharmacokinetics and safety of intravitreally delivered etanercept.

Authors:  Sascha Fauser; Hubert Kalbacher; Nils Alteheld; Kan Koizumi; Tim U Krohne; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-17       Impact factor: 3.117

Review 6.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

7.  Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan.

Authors:  Zhongli Wang; Amit Singh Yadav; Wendy Leskova; Norman R Harris
Journal:  Exp Eye Res       Date:  2010-08-19       Impact factor: 3.467

Review 8.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

9.  Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats.

Authors:  A A Bosco; A C Lerario; R F Santos; B L Wajchenberg
Journal:  Diabetologia       Date:  2003-11-04       Impact factor: 10.122

Review 10.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.